Novel Systemic Drugs for Cutaneous T-Cell Lymphoma

E-ISSN： 2212-3970|6|1|70-93

ISSN： 1574-8928

Source： Recent Patents on Anti-Cancer Drug Discovery, Vol.6, Iss.1, 2011-01, pp. : 70-93

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cutaneous T-cell Lymphoma: Molecular Genetics, Immunology and Pathogenesis

By Reinhold U. Abken H.

European Journal of Cancer, Vol. 31, Iss. 5, 1995-01 ,pp. : 793-799

Elsevier

Access to resources Recommend Favorite

ALK-Negative T-Cell Anaplastic Large Cell Lymphoma Associated with Systemic Lupus Erythematosus

By Suvajdzic Nada Stojanovic-Milenkovic Roksanda Tomasevic Zoran Cemerikic-Martinovic Vesna Mihaljevic Biljana Atkinson Henry D.E.

Medical Oncology, Vol. 20, Iss. 4, 2003-12 ,pp. : 409-412

Humana Press, Inc

Access to resources Recommend Favorite

Total skin electron beam therapy for cutaneous T-cell lymphoma: A nationwide cohort study from Denmark

By Lindahl Lise M. Kamstrup Maria R. Petersen Peter M. Wirén Johan Fenger-Grøn Morten Gniadecki Robert Iversen Lars Specht Lena

Acta Oncologica, Vol. 50, Iss. 8, 2011-11 ,pp. : 1199-1205

Informa Healthcare

Access to resources Recommend Favorite

Acute adult T-cell leukemia/lymphoma (ATL) presenting with cutaneous purpuric lesions: A rare presentation

By Oliveira Pedro D. Torres Isabelle S. M. Oliveira Rodrigo F. Bittencourt Achilééa L.

Acta Oncologica, Vol. 50, Iss. 4, 2011-05 ,pp. : 595-597

Informa Healthcare

Access to resources Recommend Favorite

Expression of special AT-rich sequence-binding protein 1 is an independent prognostic factor in cutaneous T-cell lymphoma

Oncology Reports, Vol. 33, Iss. 1, 2015-01 ,pp. : 250-266

Spandidos Publications

Access to resources Recommend Favorite